These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21812353)

  • 1. Measuring the profitability of a hospital pulmonary function laboratory: a case study.
    Kocakülâh MC; Morris JT; Kessler B
    J Health Care Finance; 2011; 37(4):36-45. PubMed ID: 21812353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using patient classification systems to identify ambulatory care costs.
    Karpiel MS
    Healthc Financ Manage; 1994 Nov; 48(11):30-4, 36-7. PubMed ID: 10146093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes).
    Dal Negro RW; Tognella S; Tosatto R; Dionisi M; Turco P; Donner CF
    Respir Med; 2008 Jan; 102(1):92-101. PubMed ID: 17881206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
    Jahnz-Rózyk K; Targowski T; From S; Płusa T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lung function test for COPD].
    Itabashi S
    Nihon Rinsho; 2003 Dec; 61(12):2150-7. PubMed ID: 14674325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of mini peak expiratory flow as a screening test for chronic obstructive pulmonary disease among the Bangkok elderly.
    Maranetra N; Chuaychoo B; Naruman C; Lertakyamanee J; Dejsomritrutai W; Chierakul N; Nana A; Thamlikitkul W; Suthamsmai T; Saengkaew S; Sreelum W; Aksornin M; Dechapol A; Reungcham C
    J Med Assoc Thai; 2003 Dec; 86(12):1133-9. PubMed ID: 14971521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for boosting outpatient care profitability.
    Baptist AJ; Lameka RB
    Healthc Financ Manage; 1990 Feb; 44(2):21-4, 26, 28. PubMed ID: 10145208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening of chronic obstructive lung disease and education of health professionals].
    Grillet Y
    Soins; 2006 Nov; (710):36-8. PubMed ID: 17225760
    [No Abstract]   [Full Text] [Related]  

  • 10. Heart failure and chronic obstructive pulmonary disease: lung function test interpretation.
    van Helvoort HA; Heijdra YF
    Eur J Heart Fail; 2009 Jun; 11(6):632; author reply 632-3. PubMed ID: 19414478
    [No Abstract]   [Full Text] [Related]  

  • 11. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic obstructive pulmonary disease: definition and classification of severity].
    Romagnoli M; Fabbri LM
    Ann Ist Super Sanita; 2003; 39(4):461-6. PubMed ID: 15098568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection.
    Bobbio A; Chetta A; Carbognani P; Internullo E; Verduri A; Sansebastiano G; Rusca M; Olivieri D
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):754-8. PubMed ID: 16140541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial of an activity and exercise adherence intervention in chronic pulmonary disease.
    Steele BG; Belza B; Cain KC; Coppersmith J; Lakshminarayan S; Howard J; Haselkorn JK
    Arch Phys Med Rehabil; 2008 Mar; 89(3):404-12. PubMed ID: 18295615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis of chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Juergens UR; Menz G
    MMW Fortschr Med; 2005 Mar; 147(11):36-8, 40. PubMed ID: 15803848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs of chronic obstructive pulmonary disease treatment].
    Targowski T; Jahnz-Rózyk K
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():86-7. PubMed ID: 15524026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stage and prognosis of COPD].
    Akashiba T
    Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic obstructive pulmonary disease: basic features, risk factors and diagnosis].
    Groneberg DA; Golpon H; Welte T
    Pneumologie; 2006 Nov; 60(11):679-89; quiz 690-3. PubMed ID: 17109266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.